- STAT+: A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker?The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by their doctor.STAT · 25d ago↗ source
- Statins and blood pressure drugs changing health risks of obesity, study suggestsNew research shows obesity patients over 40 are managing blood pressure and cholesterol as well as healthy-weight peers, but younger adults remain at risk.STAT · 25d ago↗ source
- Merck scraps a Phase 2 Alzheimer's asset from partner NeuphoriaMerck has axed a Phase 2 trial testing an experimental Alzheimer’s medicine, Endpoints News has learned. The company terminated a mid-stage test of the oral drug candidate MK-1167, a Merck spokes…